MedinCell S.A. (MEDCL.PA)
EUR 16.8
(5.53%)
EUR 16.8
(5.53%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -6.71 Million EUR | 0.0% |
| 2022 | - EUR | -100.0% |
| 2021 | 1.00 EUR | 0.0% |
| 2020 | - EUR | 0.0% |
| 2019 | - EUR | -100.0% |
| 2018 | 1.33 Million EUR | 0.98% |
| 2017 | 1.32 Million EUR | 69.58% |
| 2016 | 779 Thousand EUR | 77899900.0% |
| 2015 | 1.00 EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 1.00 EUR | 0.0% |
| 2023 Q4 | -6.71 Million EUR | 0.0% |
| 2023 FY | -6.71 Million EUR | 0.0% |
| 2022 FY | - EUR | -100.0% |
| 2022 Q4 | - EUR | 0.0% |
| 2022 Q2 | - EUR | 0.0% |
| 2021 FY | 1.00 EUR | 0.0% |
| 2021 Q2 | 1.00 EUR | 0.0% |
| 2021 Q4 | 1.00 EUR | 0.0% |
| 2020 Q2 | - EUR | 0.0% |
| 2020 Q4 | - EUR | 0.0% |
| 2020 FY | - EUR | 0.0% |
| 2019 FY | - EUR | -100.0% |
| 2019 Q2 | - EUR | 0.0% |
| 2019 Q4 | - EUR | 0.0% |
| 2018 Q4 | 4.29 Million EUR | 0.0% |
| 2018 FY | 1.33 Million EUR | 0.98% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q2 | 1.00 EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2017 Q1 | - EUR | 0.0% |
| 2017 Q3 | 1.32 Million EUR | 0.0% |
| 2017 Q4 | 1.32 Million EUR | 0.0% |
| 2017 FY | 1.32 Million EUR | 69.58% |
| 2016 FY | 779 Thousand EUR | 77899900.0% |
| 2015 FY | 1.00 EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 3138.009% |
| ABIVAX Société Anonyme | 1.00 EUR | 671400100.0% |
| Adocia SA | 272 Thousand EUR | 2568.382% |
| Aelis Farma SA | 53 Thousand EUR | 12767.925% |
| Biophytis S.A. | - EUR | Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 485.64% |
| genOway Société anonyme | 982.75 Thousand EUR | 783.184% |
| IntegraGen SA | 311.44 Thousand EUR | 2255.73% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | 4178.434% |
| Neovacs S.A. | - EUR | Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | -505.598% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 648.277% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | -5533.685% |
| Sensorion SA | - EUR | Infinity% |
| Theranexus Société Anonyme | - EUR | Infinity% |
| TME Pharma N.V. | 91 Thousand EUR | 7478.022% |
| Valbiotis SA | 1 Million EUR | 768.06% |
| TheraVet SA | 123.34 Thousand EUR | 5543.401% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | 671400100.0% |
| argenx SE | 281.12 Million EUR | 102.388% |
| BioSenic S.A. | - EUR | Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 632.857% |
| DBV Technologies S.A. | 1.00 USD | 671400100.0% |
| Galapagos NV | 73.97 Million EUR | 109.076% |
| Genfit S.A. | 4000.00 EUR | 167950.0% |
| GeNeuro SA | - EUR | Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | 671400100.0% |
| Innate Pharma S.A. | 1.00 EUR | 671400100.0% |
| Inventiva S.A. | 417 Thousand EUR | 1710.072% |
| MaaT Pharma SA | 190 Thousand EUR | 3633.684% |
| Nanobiotix S.A. | 200 Thousand EUR | 3457.0% |
| Onward Medical N.V. | 936 Thousand EUR | 817.308% |
| Oryzon Genomics S.A. | 6029.00 EUR | 111461.752% |
| OSE Immunotherapeutics SA | - EUR | Infinity% |
| Oxurion NV | 128 Thousand EUR | 5345.313% |
| Pharming Group N.V. | 51.38 Million EUR | 113.067% |
| Poxel S.A. | 2.95 Million EUR | 327.131% |
| GenSight Biologics S.A. | 1.00 EUR | 671400100.0% |
| Transgene SA | - EUR | Infinity% |
| Financière de Tubize SA | - EUR | Infinity% |
| UCB SA | 1.03 Billion EUR | 100.651% |
| Valneva SE | 44.46 Million EUR | 115.099% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | 671400100.0% |